144
Participants
Start Date
March 31, 2015
Primary Completion Date
July 1, 2020
Study Completion Date
July 1, 2020
Pembrolizumab
Memorial Sloan Kettering Cancer Center, New York
UPMC Hillman Cancer Center, Pittsburgh
Fox Chase Cancer Center, Philadelphia
Medstar Health Research Institute, Washington D.C.
Duke University, Durham
Mayo Clinic Florida, Jacksonville
H. Lee Moffitt Cancer Center, Tampa
University of Michigan, Ann Arbor
Mayo Clinic Cancer Center, Rochester
Washington University in St. Louis, St Louis
University of Southern California, Los Angeles
Oregon Health and Science University, Portland
Merck Sharp & Dohme LLC
INDUSTRY
Sarcoma Alliance for Research through Collaboration
OTHER